Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of $0.01, $0.02 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $63.55 million versus the consensus estimate of $55.78 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.